TIS 0.00% 0.0¢ tissue therapies limited

purchasing vitro gro for use in australia??, page-9

  1. 215 Posts.
    lightbulb Created with Sketch. 4
    Does anyone understand why this choice between device rule 8 & 13 would require the following?
    "It is possible that the MHRA review may result in a further referral to the European Medicines Agency (EMA) for a review of the VitroGro® ECM manufacturing process. EMA is the European Union health regulatory agency."
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.